Information Regarding a Recent Data Incident Impacting the Jansen CarePath Platform

Vitalogy Skincare learned of an incident involving potential unauthorized access to personal information contained within a database used on the Janssen CarePath platform, which is managed by International Business Machines (commonly referred to as “IBM”). If you are or have been a user of the CarePath platform, you may have already received a letter from IBM notifying you of this incident.

Janssen CarePath became aware of a technical method by which unauthorized access to the database could be obtained. Potentially affected individuals included some Vitalogy Skincare individuals who have used the Janssen CarePath platform. In August 2023, IBM’s investigation revealed that there was unauthorized access to information in the database, though IBM was unable to determine the scope of access. In October 2023, IBM notified potentially affected individuals of this incident.

IBM issued a press release that provides more information about the incident. If you have questions about whether your information was impacted, please contact us at Vitalogy Skincare takes patient privacy very seriously and is happy to address any questions or concerns you may have, including whether you were among the affected individuals.